TALENP002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TALENP002, covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)